“✌1등경산보도사무실O1O=8675=3008 카톡 bmw5366 경산유흥알바 ✌”的搜索结果，显示 41-50 项，共有 11419 项

1. 医生 - 妙佑医疗国际儿童中心 - 妙佑医疗国际儿童中心

   Nessa Aghazadeh Mohandesi, M.D.. Rochester, MN. Safia K. Ahmed, M.D.. Phoenix, AZ.

2. 妙佑医疗国际眼科- 临床试验

   To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

3. 血液科- 临床试验- 妙佑医疗国际

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...

4. 妇产科- 临床试验- 妙佑医疗国际

   The investigators have chosen this population because 1) These mutations are the most common genetic causes of LQTS, and 2) Offspring will have high risk of ...

5. 妙佑医疗国际眼科- 临床试验

   Jacksonville, Fla. The purpose of this study is to evaluate the clinical outcomes of the Micropulse Trans-Scleral Cyclophotocoagulation Laser (MPTSCPC) after 1 ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

7. 医生 - 检验医学与病理学- 妙佑医疗国际

   Hussam Al Kateb, Ph.D. Rochester, MN. Sam T. Albadri, M.B., Ch.B. Rochester, MN. Priya P. Alexander, M.D.. Rochester, MN. Alicia Algeciras-Schimnich, Ph.D.

8. 急诊医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine the utility of physical therapy services in the Emergency Department through a prospective ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...